Breeze Meds vs HumeCare+
Breeze Meds' tablet bundles are the tell: $899 for three months and $1,799 for six both work out fractionally above its own monthly figure.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Breeze Meds
Partner
$299/mo
$199 for injectable semaglutide, rising to $399 for injectable tirzepatide — and the oral semaglutide at $299 costs more than the injection, which is worth checking against your assumption about which route is cheaper.
- A figure for every product, on the homepage
- Four partner pharmacies named with phone numbers
- Fifty-state coverage stated in the FAQ
- Both molecules in both routes
- The $200 step from semaglutide to tirzepatide is wide
- Oral semaglutide costs $100 more than the injection
- “Starting at” leaves the dose ladder unstated
- The cost FAQ answers a different question
Pick it for: Switching routes or molecules without changing sellers
Not for: Anyone heading for tirzepatide on a budget, or who needs the ladder stated.
HumeCare+
Partner
$199/mo
HumeCare+ holds $199 a month for compounded semaglutide at every dose, injection or pill, and $299 for tirzepatide, so titration carries no price increase. The anchor struck through beside $199 is presented as a limited-time offer with no start date, no end date and no page stating when it was charged.
- One price at every dose, so titration costs nothing extra
- The compounded disclosure appears on the seller's own pages
- Semaglutide is offered as an injection or a pill at the same price
- A body-composition device is included rather than sold separately
- The struck-through list price carries no date on any page
- Tirzepatide is sold only as a B12 and glycine combination
- Two landing pages print the price in pounds rather than dollars
- Coverage is 47 states, not all 50
Pick it for: Paying the same whether you swallow it or inject it
Not for: Anyone who wants plain tirzepatide with nothing added.
Our verdict
Only the year moves, and only by 2.5% — $3,498 — so no term at Breeze Meds makes the tablet cheaper, and “starting at” leaves the ladder open above all of them. HumeCare+ charges the same for the pill as for the shot, so the route is a clinical decision rather than a paid-for one, and the program ends with a physician-managed taper rather than simply stopping.
What actually separates them
Breeze Meds and HumeCare+ state different things about published price and where you can use it. Everything else they publish, they publish the same way.
Breeze Meds costs $100 more than HumeCare+ — 50% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $2,388 at HumeCare+ against $3,588 at Breeze Meds — a difference of $1,200.
| Breeze Meds | HumeCare+ | |
|---|---|---|
| Published price | $299/mo | $199/mo |
| Where you can use it | 50 states | 47 states |
What neither of them tells you
A comparison that only reports differences implies everything else is settled. Here it is not.
- Neither publishes a milligram dose, so neither price can be compared with the other — or with anything else.
Before you choose either
Neither of these sellers publishes a milligram dose, so neither price can be compared with the other or with anything else — which is normal in this category and is exactly the problem. Ask both what dose the monthly price buys, and see the sellers that do publish one before you assume the cheaper sticker is the cheaper product.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.